HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cosmetics Industry In Perplexing Spot: A Trusted Voice, But What Exactly Is The Conversation?

Executive Summary

The year 2022 could be a ripe opportunity for industry to inform public opinion amid sweeping policy changes that stand to transform the global cosmetics sector. Consumers may be inclined to listen when business speaks, but that doesn’t mean they’ll like the conversation.

You may also be interested in...

Sensodyne, Nature Made Among Pharmacists’ ‘Most Trusted’ OTC Brands, Survey Says

The inaugural BrandSpark/Newsweek Most Trusted by Pharmacists Awards honors brands in 86 OTC product categories based on unaided citations by surveyed pharmacists.

Clean And Sustainable Beauty & Personal Care News: Sensegen, SOLESPHERE, Dial Soap Refills

Henkel’s Dial soap brand launches Concentrated Refills, soap packets that use 95% less plastic compared with a replacement soap bottle. On the ingredient front, biotech Sensegen is targeting the taste, smell and beauty markets with novel ingredients that it says are plant-based and gentler on the planet than agriculturally derived or petroleum-based ingredients. More news in brief.

Hawaii Considers Sweeping Ban On ‘Chemical’ UV Filters, Taking Cues From US FDA

Following Maui County’s example, Hawaii state lawmakers seem intent on limiting OTC sunscreen sales to products formulated with zinc oxide and titanium dioxide, the only active ingredients upheld as GRASE by the US FDA in recent rulemaking overtures.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts